LOMBARDO, VALENTINA NUNZIELLA
LOMBARDO, VALENTINA NUNZIELLA
Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report
2025-01-01 Lombardo, Valentina; Scandurra, Giuseppa; Pettinato, Angela; Scaglione, Giovanni Luca; Scollo, Paolo; Capoluongo, Ettore D.
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful?
2024-01-01 Scandurra, G.; Lombardo, V.; Scibilia, G.; Sambataro, D.; Gebbia, V.; Scollo, P.; Pecorino, B.; Valerio, M. R.
Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment
2025-01-01 Scaglione, Giovanni Luca; Lombardo, Valentina; Polano, Maurizio; Scandurra, Giuseppa; Pettinato, Angela; Giunta, Corrado; Iemmolo, Rosario; Scollo, Paolo; Capoluongo, Ettore D
Trabectedin maintenance therapy after liposomal doxorubicin plus trabectedin combination in patients with relapsed ovarian cancer: the randomized, phase II TRAMANT study
2025-01-01 Scandurra, Giuseppa; Scibilia, Giuseppe; Lombardo, Valentina; Savarese, Antonella; De Angelis, Carmine; Scalone, Simona; Geuna, Elena; Tuninetti, Valentina; Valabrega, Giorgio; Ardizzoia, Antonio; Zamagni, Claudio; Salutari, Vanda; Scambia, Giovanni; Scollo, Paolo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report | 1-gen-2025 | Lombardo, Valentina; Scandurra, Giuseppa; Pettinato, Angela; Scaglione, Giovanni Luca; Scollo, Paolo; Capoluongo, Ettore D. | |
| New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? | 1-gen-2024 | Scandurra, G.; Lombardo, V.; Scibilia, G.; Sambataro, D.; Gebbia, V.; Scollo, P.; Pecorino, B.; Valerio, M. R. | |
| Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment | 1-gen-2025 | Scaglione, Giovanni Luca; Lombardo, Valentina; Polano, Maurizio; Scandurra, Giuseppa; Pettinato, Angela; Giunta, Corrado; Iemmolo, Rosario; Scollo, Paolo; Capoluongo, Ettore D | |
| Trabectedin maintenance therapy after liposomal doxorubicin plus trabectedin combination in patients with relapsed ovarian cancer: the randomized, phase II TRAMANT study | 1-gen-2025 | Scandurra, Giuseppa; Scibilia, Giuseppe; Lombardo, Valentina; Savarese, Antonella; De Angelis, Carmine; Scalone, Simona; Geuna, Elena; Tuninetti, Valentina; Valabrega, Giorgio; Ardizzoia, Antonio; Zamagni, Claudio; Salutari, Vanda; Scambia, Giovanni; Scollo, Paolo |